Company invites individual and institutional investors as well as advisors to log on to VirtualInvestorConferences.com to view presentation EUGENE, Ore., Oct. 22, 2018 /PRNewswire/ -- Arcimoto, Inc.®

Protagonist Therapeutics, Inc. (Nasdaq: PTGX) today presented clinical data from the PROPEL study of PTG-100, the Company's oral, gut-restricted alpha-4-beta-7 integrin antagonist peptide for the...

Today at Sibos, the world's premier financial services event, LexisNexis Risk Solutions unveiled innovative product initiatives that will transform the way banks and companies in other industries...

Oracle OpenWorld 2018 will be the launch pad for RapidBlocksTM, the revolutionary Blockchain SaaS tool by AuraBlocks. The AuraBlocks team, along with other industry leaders, will be presenting...

Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced the presentation of data from two clinical trials for PEGPH20 (pegvorhyaluronidase alfa) in patients with advanced pancreas and...

Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today reported the results from the exploratory Phase 1b study of the gut-selective pan-Janus kinase (JAK)...

dotData, the first and only company focused on delivering end-to-end data science automation and operationalization for the enterprise, today announced the availability of Version 1.2 of its...

Genomic Health, Inc. (Nasdaq: GHDX) today announced results from multiple studies of its Oncotype DX® tests highlighting their value in optimizing treatment for patients with various stages of...

The Resource Management Institute, dedicated to the advancement of resource and workforce management thought leadership, has concluded their inaugural Resource Management Global Symposium. The...

Naveris, Inc., a private biotechnology company developing blood tests for early cancer detection, congratulates Bhisham Chera, M.D. and Gaorav Gupta, M.D., Ph.D., scientific advisors and co-chairs...